Roggendorf, Michael

Publishing since 1980 (Dinosaur)

Has published 233 publications in 31 years

Number of publications published per year by Roggendorf, Michael. (Source : PubMed)

Distribution of publications types for Roggendorf, Michael. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Maier T, Schwarting A, Mauer D, Ross RS, Martens A, Kliem V, Wahl J, Panning M, Baumgarte S, Müller T, Pfefferle S, Ebel H, Schmidt J, Tenner-Racz K, Racz P, Schmid M, Strüber M, Wolters B, Gotthardt D, Bitz F, Frisch L, Pfeiffer N, Fickenscher H, Sauer P, Rupprecht CE, Roggendorf M, Haverich A, Galle P, Hoyer J, Drosten C. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus.  Clin. Infect. Dis.  2010;50;8  
•  Wu C, Zhang X, Tian Y, Song J, Yang D, Roggendorf M, Lu M, Chen X. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.  J. Gen. Virol.  2010;91;Pt 2  
•  Viazov S, Ross SS, Kyuregyan KK, Timm J, Neumann-Haefelin C, Isaeva OV, Popova OE, Dmitriev PN, El Sharkawi F, Thimme R, Michailov MI, Roggendorf M. Hepatitis C virus recombinants are rare even among intravenous drug users.  J. Med. Virol.  2010;82;2  
•  Neumann-Haefelin C, Timm J, Schmidt J, Kersting N, Fitzmaurice K, Oniangue-Ndza C, Kemper MN, Humphreys I, McKiernan S, Kelleher D, Lohmann V, Bowness P, Huzly D, Rosen HR, Kim AY, Lauer GM, Allen TM, Barnes E, Roggendorf M, Blum HE, Thimme R. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.  Hepatology  2010;51;1  
•  Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.  Immunology  2009  
•  Giugliano S, Oezkan F, Bedrejowski M, Kudla M, Reiser M, Viazov S, Scherbaum N, Roggendorf M, Timm J. Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.  Hepatology  2009;50;3  
•  Hitziger T, Schmidt M, Schottstedt V, Hennig H, Schumann A, Ross S, Lu M, Seifried E, Roggendorf M. Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity.  Transfusion  2009;49;7  
•  Oniangue-Ndza C, Aus dem Siepen M, Lohmann V, Wiese M, Viazov S, Roggendorf M. In vitro replicative properties of replicons constructed using sequence variants of the hepatitis C virus strain AD78 that caused a single-source outbreak of hepatitis C.  Virus Res.  2009;142;1-2  
•  Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, Bucchi A, Sowa JP, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.  Hepatology  2009;49;4  
•  Weseslindtner L, Neumann-Haefelin C, Viazov S, Haberstroh A, Kletzmayr J, Aberle JH, Timm J, Ross SR, Klauser-Braun R, Baumert TF, Roggendorf M, Thimme R, Holzmann H. Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability.  J. Hepatol.  2009;50;4  

[ See timeline ] [ See all publications ]